CorMedix Inc. - Common stock, $0.001 par value (CRMD)

Historical Holders from Q1 2019 to Q3 2025

Symbol: CRMD on Nasdaq
Type / Class: Equity / Common stock, $0.001 par value
Shares outstanding: 78,783,577
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 43,110,702
Holdings value: $501,386,081
% of all portfolios: 0.002%
Number of holders: 188
Number of buys: 140
Number of sells: -58
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CorMedix Inc. - Common stock, $0.001 par value (CRMD)

Filer	Ownership	Holdings Value	Net Change	Nb Shares	Reporting Name	Report Period
Deep Track Capital, LP	6.29%	$55,204,125		4,955,487	Deep Track Capital, LP	21 Nov 2025
SHAIBATALHAMD AYMEN ABDALKADER	6.2%	$52,123,969	+$52,123,969	4,645,630	SHAIBATALHAMD AYMEN ABDALKADER	08 Aug 2025
BlackRock, Inc.	7.5%	$41,659,221		4,567,897	BlackRock, Inc.	31 Dec 2024

Institutional Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	43,110,702	$501,386,081	+$101,791,266	$15,143,423	$15,473,715	$11.63	188
2025 Q2	34,151,234	$420,699,898	+$142,837,808	$6,911,398	$10,694,248	$12.32	169
2025 Q1	23,724,937	$146,235,596	+$397,499	$4,815,472	$2,981,882	$6.16	135
2024 Q4	22,893,836	$185,441,545	+$29,955,443	$3,244,050	$4,853,520	$8.1	126
2024 Q3	19,135,638	$154,655,147	+$21,831,393	$3,565,263	$1,081,776	$8.08	100
2024 Q2	17,129,390	$74,162,669	-$748,246	$1,551,439	$305,265	$4.33	97
2024 Q1	17,269,642	$73,216,929	-$5,693,027	$1,240,624	$393,896	$4.24	89
2023 Q4	18,742,007	$70,461,032	+$3,045,526	$1,071,600	$394,048	$3.76	101
2023 Q3	17,891,223	$66,197,207	-$5,485,628	$1,498,500	$294,520	$3.7	92
2023 Q2	19,187,043	$76,065,204	+$33,053,416	$1,106,789	$434,785	$3.96	86
2023 Q1	10,770,110	$44,582,136	-$1,863,278	$1,020,480	$669,536	$4.14	64
2022 Q4	11,182,776	$47,050,210	+$1,816,100	$1,240,262	$280,926	$4.22	62
2022 Q3	10,928,271	$31,131,890	-$4,497,215	$417,000	$230,000	$2.83	66
2022 Q2	12,425,504	$49,348,797	-$5,601,808	$440,000	$220,000	$4.02	69
2022 Q1	13,362,668	$73,354,516	+$1,886,576	$618,000	$458,000	$5.48	83
2021 Q4	13,046,114	$59,435,463	+$5,549,733	$299,000	$315,000	$4.55	78
2021 Q3	11,793,247	$54,910,109	+$1,590,384	$377,000	$534,000	$4.65	75
2021 Q2	11,351,356	$77,873,368	+$3,221,689	$926,000	$1,683,000	$6.86	77
2021 Q1	10,781,064	$107,630,096	+$16,345,897	$1,737,000	$3,224,000	$9.99	76
2020 Q4	9,261,298	$68,791,909	+$7,239,796	$1,162,000	$593,000	$7.43	74
2020 Q3	8,327,514	$50,205,664	+$9,581,252	$583,000	$433,000	$6.03	70
2020 Q2	6,739,459	$42,456,689	+$1,328,313	$781,000	$252,000	$6.3	67
2020 Q1	6,612,416	$23,732,293	-$6,155,816	$457,000	$47,000	$3.59	57
2019 Q4	6,440,146	$46,873,565	+$176,523	$793,000	$104,000	$7.28	62
2019 Q3	6,472,987	$41,291,108	+$6,489,686	$497,000	$163,000	$6.38	55
2019 Q2	5,421,031	$48,610,180	+$15,505,635	$1,010,000	$1,581,000	$8.97	45
2019 Q1	3,663,429	$34,616,000	+$34,616,000	$1,543,000	$1,747,000	$9.45	37